Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05682391
Other study ID # 202207083RINA
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date March 2, 2023
Est. completion date December 31, 2025

Study information

Verified date April 2024
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative cerebrospinal fluid (CSF) leakage is a well-known complication that might occur after transnasal transsphenoidal adenomectomy at an incidence of 0.5-15% according to different literature reports. Persistent CSF leakage may lead to intracranial hypotension or meningitis, therefore aggressive management is mandatory. The treatment is immediate repair during transsphenoidal surgery once intraoperative CSF leakage is identified, with the adjunct of postoperative bed rest and/or lumbar drainage. However, due to the advances in endoscopic endonasal skull base surgery, some surgical teams have advocated that postoperative bed rest may not be necessary if appropriate repair have been performed. High-flow CSF leakage typically occurs in an extended endonasal approach to the anterior or posterior cranial fossa, whereas CSF leakage resulting from transsphenoidal pituitary surgery is usually easier to be repaired. Bed rest is stressful management for patients and poses increased risks in many ways, such as the need for an indwelling urinary catheter, musculoskeletal pain, affected sleep quality, and increased possibility of thromboembolism. It is crucial that the duration of bed rest be cut short or totally avoided if clinically acceptable. In reviewing the literature, there is insufficient evidence supporting the routine use of postoperative bed rest after CSF leakage repair in transsphenoidal surgery. This study aims to compare the efficacy of successful CSF leakage repair with or without postoperative bed rest with an open-label randomized trial design.


Description:

Postoperative CSF leakage is a well-known complication that might occur after transnasal transsphenoidal adenomectomy at an incidence of 0.5-15% according to different literature reports. Persistent CSF leakage may lead to intracranial hypotension or meningitis, therefore aggressive management is mandatory. The reason that a postoperative CSF leakage would occur mostly is due to the rupture of arachnoid membrane caused by intraoperative manipulation, resulting in direct communication between the subarachnoid space and the nasal cavity. Even when in cases without intraoperative CSF leakage detected, there is a reported incidence of 1.3% of postoperative CSF leakage. The rate of intraoperative CSF leakage varies in different tumor sizes, tumor extents, tumor natures, and surgical teams, and it could not be precisely documented as 23.3-60% were reported. The treatment is immediate repair during transsphenoidal surgery once intraoperative CSF leakage is identified, with the adjunct of postoperative bed rest and/or lumbar drainage. However, due to the advances in endoscopic endonasal skull base surgery, some surgical teams have advocated that postoperative bed rest may not be necessary if appropriate repair have been performed. High-flow CSF leakage typically occurs in an extended endonasal approach to the anterior or posterior cranial fossa, whereas CSF leakage resulting from transsphenoidal pituitary surgery is usually easier to be repaired. Bed rest is stressful management for patients and poses increased risks in many ways, such as the need for an indwelling urinary catheter, musculoskeletal pain, affected sleep quality, and increased possibility of thromboembolism. It is crucial that the duration of bed rest be cut short or totally avoided if clinically acceptable. In reviewing the literature, there is insufficient evidence supporting the routine use of postoperative bed rest after CSF leakage repair in transsphenoidal surgery. This study aims to compare the efficacy of successful CSF leakage repair with or without postoperative bed rest with an open-label randomized trial design.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 180
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Patients with pituitary adenoma requiring surgical resection. Exclusion Criteria: - Spontaneous CSF leakage occurs prior to transsphenoidal surgery. - The growth of adenoma extends to anterior cranial fossa or clival region. - The growth of adenoma extends to 3rd ventricle. - Prior history of transsphenoidal surgery. - Prior history of radiotherapy or radiosurgery to the sella or nearby skull base region. - Class 2 obesity or extremely obese: BMI ?35. - Pregnant or lactating women. - Patients who could not give informed consent.

Study Design


Intervention

Other:
Bed rest
Strict bed rest ordered after surgery that does not allow the participant to elevate the head of bed over 30 degrees

Locations

Country Name City State
Taiwan Division of Neurosurgery, Department of Surgery, National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of CSF leakage within 3 months postoperatively Any documented CSF leakage within 3 months postoperatively. Confirmation of CSF leakage could either be:
typical symptoms of CSF rhinorrhea, plus visible clear and colorless rhinorrhea with positive glucose response
atypical symptoms of CSF rhinorrhea, plus visualization of clear and colorless fluid from the operative site via sinoscope
atypical symptoms of CSF rhinorrhea, plus identifiable fluid accumulation in the sphenoid sinus and suspicious site of CSF fistula via neuroimaging modalities
12 weeks after the date of surgery
Secondary Occurrence of meningitis within 3 months postoperatively Any documented meningitis within 3 months postoperatively. 12 weeks after the date of surgery
Secondary Length of hospital stay The length of stay is calculated from 1 day prior to surgery until the day of discharge. 24 weeks after the date of surgery
Secondary Results of 36-Item short form health survey (SF-36) surveys SF-36 with its 8 subscales as well as the physical component summary (PCS) and mental component summary (MCS) scores. Each of the 8 subscales (physical functioning [PF], role physical [RP], bodily pain [BP], general health [GH], vitality [VT], social functioning [SF], role emotional [RE], and mental health [MH]) has a minimum value of 0 and maximum value of 100, a higher score relates to a better outcome. The PCS score is the average score of PF, RP, BP, and GH, while the MCS score is the average score of VT, SF, RE, and MH (both has the minimum value of 0 and maximum value of 100, a higher score relates to a better outcome). On postoperative day 1, postoperative day 7, postoperative day 28, postoperative week 12 and postoperative week 24.
See also
  Status Clinical Trial Phase
Completed NCT05024643 - Endoscopic Repair of Frontal Sinus CSF Leak
Completed NCT03280849 - Chitosan Scaffold for Sellar Floor Repair in Endoscopic Endonasal Transsphenoidal Surgery N/A
Recruiting NCT05792683 - Comparison of Duration of CSF Leak in Post Traumatic Patients Managed by Early Lumbar Drain vs Conservative Treatment N/A
Not yet recruiting NCT04784169 - Free Middle Turbinate Flap for Repair of Low Flow Cerebrospinal Fluid Leak N/A